GENB:NASDAQ
Generate Biomedicines Inc
$14.86
arrow_upward
+15.10%(+1.95) 1D
Jun 4, 11:53:40 AM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GENB...
Open
$12.91
High
$15.05
Low
$12.84
Mkt. cap
1.89B
Avg. vol.
564.04K
Volume
1.26M
52-wk high
$16.75
52-wk low
$11.00
EPS
-$1.96
No. of employees
312
Open
$12.91
High
$15.05
Low
$12.84
Mkt. cap
1.89B
Avg. vol.
564.04K
Volume
1.26M
52-wk high
$16.75
52-wk low
$11.00
EPS
-$1.96
No. of employees
312
Analyst outlook
Analyst Ratings
Based on 6 analysts giving stock ratings to GENB in the past 3 months
Strong Buy
Buy
6
Hold
0
Sell
0
12 month forecast
Based on 6 Wall Street analysts offering 12 month price targets for GENB in the last 3 months.
Highest
Current $14.86
$30.00 (+101.88%)
Average
$25.40 (+70.93%)
Lowest
$22.00 (+48.05%)
News stories
From sources across the web
Quiver Quantitative
·
1 hour ago
$GENB stock is up 14% today. Here's what we see in our data.
Profile
Generate:Biomedicines is a biotechnology company founded in 2018 and headquartered in Somerville, Massachusetts. It specializes in using machine learning to design and optimize proteins for therapeutic applications, with a focus on immunology, oncology, and infectious diseases. Wikipedia
About Generate Biomedicines Inc
CEO-
Employees312
Founded2018
HeadquartersSomerville, Massachusetts, United States
SectorBiotechnology
Websitegeneratebiomedicines.com
AI content may include mistakes. Learn more